Nucleotides have at least 5 essential cellular roles. One of the most important roles is that they are the building blocks of DNA and RNA, thus affecting cellular growth and proliferation. Enzymes involved in nucleotide biosynthesis are therapeutic targets for several drugs including anti-microbial, anti-viral and anti-cancer drugs.

This educational content details how the liver regulates cholesterol through both its internal production and the absorption of particles from the bloodstream. When a patient takes statin medications, the drug blocks a specific enzyme to inhibit cholesterol synthesis within liver cells. This internal shortage triggers the liver to increase its production of surface receptors designed to capture low-density lipoprotein (LDL) from the blood. Consequently, these extra receptors effectively pull more LDL out of circulation, leading to a significant drop in overall plasma cholesterol levels. By explaining this biological feedback loop, the source clarifies the primary mechanism behind how common heart medications improve cardiovascular health.

Lipolysis in adipose tissue is initiated by activation of Hormone-Sensitive Lipase by epinephrine during fasting. The fatty acids released in the bloodstream provide an alternative fuel source for other tissues like the liver and muscle. This switch to using fatty acids for energy spares glucose use during fasting. In addition, excess acetyl CoA in the liver is used to produce ketone bodies that can serve as an alternative energy source for many tissues.

Following a meal, the pancreas releases insulin to manage elevated blood sugar levels by altering how various tissues process nutrients. This hormone primarily targets the liver, muscles, and fat cells to encourage the storage of energy while preventing the release of internal fuel reserves. Specifically, insulin facilitates the movement of glucose from the bloodstream into cells via specialized transporters and promotes the synthesis of glycogen and fats. Simultaneously, it halts processes like gluconeogenesis and lipolysis, ensuring that the body stops producing sugar and breaking down fat when food is available. By coordinating these stimulatory and inhibitory actions, insulin effectively maintains metabolic balance and nutrient distribution. The overall process shifts the body into an anabolic state, focusing on cellular uptake and long-term energy conservation.

Metabolism involves a structured three-stage breakdown of nutrients to provide the body with energy. The initial phase takes place in the digestive tract, where complex foods like proteins and fats are reduced to their basic building blocks before entering the blood. During the second stage, these smaller units travel into cells to be processed within the cytoplasm and mitochondria, creating high-energy molecules through pathways like glycolysis and the TCA cycle. The final phase occurs deep inside the mitochondrial membrane, focusing on converting those molecules into ATP. This essential end product serves as the primary fuel source for all cellular activities. By following this sequence, the body efficiently transforms dietary intake into usable biological power.

Triacylglycerol, the major (90%) dietary fat is processed specifically by 3 distinct lipases with 3 distinct compartments, resulting in digestion, absorption, reassembly, transport and uptake by tissues. During fasting, lipoprotein lipase mobilizes stored triacylglycerol in adipose tissue, releasing fatty acids to the bloodstream and providing an alternative energy source for several tissues.

The body cannot store excess amino acids, so they are used for protein synthesis or energy. During catabolism, nitrogen is converted into toxic ammonia, which the urea cycle safely removes. Remaining carbon skeletons are repurposed for fuel by producing glucose or acetyl CoA which are both catabolized to produce energy.

This podcast summarizes 5 key features of glycolysis: 1. Purpose of glycolysis ; 2. Tissues and Cellular compartments; 3. Energy output; 4. Regulation of rate-limiting enzymes; and 5. Clinical correlates (pyruvate kinase are deficiency).